跳至主要内容
临床试验/NCT06343129
NCT06343129已完成不适用

Effects of an Education Program Emphasizing a Whole-food, Plant-based Nutrition Program on Blood Pressure and Blood Potassium Levels in Subjects With Chronic Kidney Disease

University of Rochester4 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2020年10月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
4
主要终点
Mean change in diastolic blood pressure

研究概览

简要总结

The purpose of this study is to determine if an educational program emphasizing a whole food plant based diet favorably impacts blood pressure while not significantly increasing blood potassium levels, by comparing a group of patients receiving the educational program with a control group of patients receiving no specific education.

详细描述

The primary objective of this study is to test the hypothesis that educating hypertensive chronic kidney disease (CKD) stage 3 and 4 patients on the benefit of a whole food plant based (WFPB) diet in the context of a 15-day educational program ("Jumpstart program") will lead to improved blood pressure control and will not increase rates of hyperkalemia.

Other objectives:

A) To test the effect of the Jumpstart program on degree of uptake on a WFPB diet via a 3 day food recall.

B) To test the effect of the Jumpstart program on other important outcomes in CKD in the following domains:

  1. Body composition such as weight and body mass index (BMI).
  2. Quality of life.
  3. Laboratory tests including- serum levels of sodium, bicarbonate, chloride, Blood urea nitrogen, creatinine, calcium, phosphorus, magnesium, albumin, parathyroid hormone, fibroblast growth factor 23, lipids, C-reactive protein and erythrocyte sedimentation rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than 18 years
  • Subjects with CKD 3 and 4 (as determined by an estimated glomerular filtration rate of ≥ 15 ml/min but < 60 ml/min for at least three months)
  • Subjects with hypertension, defined as use of antihypertension medication:
  • Lack of significant proteinuria ( subjects will have a 24 hour urine protein value of < 500 mg or a spot protein to creatinine ratio of < 0.5 or a microalbumin to creatinine ratio < 300) within previous 3 months.
  • Fluent in English language
  • Able and willing to comply with the testing schedule and the meeting schedule of the Jumpstart
  • Able and willing to comply with dietary advice of whole-food plant based diet given during the educational session
  • Able and willing to give informed consent
  • Must have computer/internet access to participate in virtual Zoom educational sessions (intervention group only)

排除标准

  • Kidney disease requiring immunosuppressive therapy
  • Diabetes mellitus
  • Pregnancy
  • Life expectancy < 12 months
  • History of solid organ transplant or anticipated solid organ transplant in next 2 months
  • History of hyperkalemia: (two or more potassium levels ≥ 5.0 Meq/L or those requiring intervention for high potassium levels within the last six months)
  • Subjects with malabsorptive syndromes
  • Subjects with history of bariatric surgery or planned bariatric surgery in the next 2 months
  • Subjects on warfarin
  • Subjects with documented eating disorder at the time of consent
  • Allergy or intolerance of a plant-based or plant-derived food (gluten, soy, etc.)
  • Following a vegan diet in the six months prior to consent
  • Major surgery within 60 days prior to consent

结局指标

主要结局

Mean change in diastolic blood pressure

时间窗: Baseline to day 15

Unit of measurement - mm Hg

Proportion of participants developing hyperkalemia

时间窗: Day 15

Percentage

Mean change in systolic blood pressure

时间窗: Baseline to day 15

Unit of measurement - mm Hg

Mean change in potassium levels

时间窗: Baseline to day 15

Unit of measurement - mEq/L

次要结局

  • Mean change in high density lipoprotein (HDL) measured in blood(Baseline to day 15)
  • Mean change in sodium measured in blood(Baseline to day 15)
  • Mean change in fibroblast growth factor (FGF)-23 measured in blood(Baseline to day 15)
  • Mean change in % calories from fat(Baseline to day 15)
  • Mean change in Vegetable protein(Baseline to day 15)
  • Mean change in bicarbonate measured in blood(Baseline to day 15)
  • Mean change in energy/kg of body mass(Baseline to day 15)
  • Mean change in % calories from carbohydrates(Baseline to day 15)
  • Mean change in Animal protein(Baseline to day 15)
  • Mean change in % calories from protein(Baseline to day 15)
  • Mean change in magnesium(Baseline to day 15)
  • Mean change in sodium(Baseline to day 15)
  • Mean change in body mass(Baseline to day 15)
  • Mean change in chloride measured in blood(Baseline to day 15)
  • Mean change in blood urea nitrogen (BUN) measured(Baseline to day 15)
  • Mean change in creatinine measured in blood(Baseline to day 15)
  • Mean change in glucose measured in blood(Baseline to day 15)
  • Mean change in calcium measured in blood(Baseline to day 15)
  • Mean change in phosphorous measured in blood(Baseline to day 15)
  • Mean change in erythrocyte sedimentation rate (ESR) measured in blood(Baseline to day 15)
  • Mean change in 8-isoprostane measured in urine(Baseline to day 15)
  • Mean Change in energy/day(Baseline to day 15)
  • Mean change in total fat(Baseline to day 15)
  • Mean change in cholesterol(Baseline to day 15)
  • Mean change in Total fiber per 1000 kcal(Baseline to day 15)
  • Mean change in magnesium measured in blood(Baseline to day 15)
  • Mean change in Total dietary fiber(Baseline to day 15)
  • Mean change in phosphorous(Baseline to day 15)
  • Mean change in parathyroid hormome (PTH) measured in blood(Baseline to day 15)
  • Mean change in low density lipoprotein (LDL) measured in blood(Baseline to day 15)
  • Mean change in calcium(Baseline to day 15)
  • Mean change in body mass index(Baseline to day 15)
  • Mean change in albumin measured in blood(Baseline to day 15)
  • Mean change in burden of kidney disease(Baseline to day 15)
  • Mean change in potassium(Baseline to day 15)
  • Mean change in symptoms(Baseline to day 15)
  • Mean change in Medical Outcomes Study Short Form (MOS SF-12) physical composite(Baseline to day 15)
  • Mean change in total cholesterol measured in blood(Baseline to day 15)
  • Mean change in triglycerides measured in blood(Baseline to day 15)
  • Mean change in effects of kidney disease(Baseline to day 15)
  • Mean change in Medical Outcomes Study Short Form (MOS SF-12) mental composite(Baseline to day 15)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Liebman

Professor of Medicine, Division of Nephrology

University of Rochester

研究点 (4)

Loading locations...

相似试验